2020
Jensen IS , Hathway J, Cyr PL , Gauden D, Gardiner P. 2020. Cost–consequence analysis of 18 F-fluciclovine for the staging of recurrent prostate cancer. J Mark Access Health Pol 8(1):1749362; doi: 10.1080/20016689.2020.1749362 .
View Abstract
Publication: Manuscripts
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 .
View Abstract
Publication: Manuscripts
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. Budget impact of improving adherence to colorectal cancer screening. Abstract PCN148 . ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. The impact of increasing mt-sDNA use among colorectal cancer screeners in a US employer population. Abstract PCN145 . ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. Consequences of increasing mt-sDNA utilization among colorectal cancer screening strategies from a payer perspective. American Society of Preventative Oncology 44th Annual ASPO Conference, 2020.
Publication: Abstracts and Presentations
2019
Danese MD, Katz A, Cetin K, Chia V, Gleeson ML, Kelsh M , et al. 2019. Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data. Leuk Lymphoma 60(8):2015–2024.
View Abstract
Publication: Manuscripts
Bylsma LC , Dean RGK, Lowe K, Sangaré L, Alexander D, Fryzek J. 2019. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Cancer Med 8(12):5800-5809; doi: 10.1002/cam4.2413 .
View Abstract
Publication: Manuscripts
Sacks NC , Sharma A, Cyr PL , Stong L, Dahdal DN. Real-world evidence comparison of colorectal cancer screening outcomes with different colorectal cancer preparation agents in adults 65 years and older. Digestive Disease Week Annual Meeting, San Diego, May 2019.
Publication: Abstracts and Presentations
Hathway J, Jensen IS , Cyr PL , Koshy, TI, Parks, P, Weinstein MC. Economic analysis of colorectal cancer screening from multiple stakeholder perspectives: Key components to improve practical applications in the US. ISPOR 24th Annual International Meeting, New Orleans LA, 2019
Publication: Abstracts and Presentations
Bylsma LC , Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.
A Division of